2026-01-04 - Analysis Report
Okay, here's a comprehensive analysis of UnitedHealth Group (UNH) based on the provided data, broken down step-by-step as requested.

**0) Report in English with Simple Numbers and Analysis:**

**1) Return Rate Comparison:**

*   **Ticker:** UNH (UnitedHealth Group Inc) - A diversified health care company.
*   **UNH Cumulative Return:** -20.24%
*   **S&P 500 (VOO) Cumulative Return:** 91.00%
*   **Divergence:**
    *   **Current:** -111.2
    *   **Min:** -124.6
    *   **Max:** 29.8
    *   **Relative Divergence:** 8.7

**Analysis:** UNH has significantly underperformed the S&P 500. The divergence is substantial and currently sits near the low end of its historical range. This suggests considerable underperformance relative to the broader market.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD     | Alpha    | Beta   | Cap(B) |
|------------|---------|---------|----------|--------|--------|
| 2016-2018  | 22.0%   | 18.6%   | 19.0%    | 0.9    | 225.7  |
| 2017-2019  | 27.0%   | 18.6%   | 10.0%    | 0.9    | 266.3  |
| 2018-2020  | -41.0%  | 32.5%   | -62.0%   | 1.1    | 317.7  |
| 2019-2021  | 16.0%   | 32.5%   | -27.0%   | 1.1    | 454.9  |
| 2020-2022  | 0.0%    | 31.5%   | 2.0%     | 0.9    | 480.3  |
| 2021-2023  | 23.0%   | 13.4%   | 23.0%    | 0.5    | 476.9  |
| 2022-2024  | -24.0%  | 23.1%   | -44.0%   | 0.4    | 458.2  |
| 2023-2025  | -55.0%  | 58.5%   | -118.0%  | 0.3    | 299.0  |

*   **CAGR (Compound Annual Growth Rate):** Varies significantly.  Strong growth in earlier periods (2016-2019) turned into significant declines recently (2018-2020, 2022-2025)
*   **MDD (Maximum Drawdown):** Increasing volatility and risk recently.
*   **Alpha:** Significant negative alpha indicates underperformance relative to its risk-adjusted benchmark. Especially, 2018-2020, 2019-2021, 2022-2024, 2023-2025 are all low alpha section.
*   **Beta:** Beta has generally declined, meaning the price of stock is less corelated with market volatility.
*   **Cap(B) (Market Capitalization in Billions):** Generally increasing until recently, indicating investor confidence that has since decreased.

**2) Recent Stock Price Fluctuations:**

*   **Current Close:** 336.40
*   **Last-market:** price = 336.4, previousClose = 330.11, change = 1.91
*   **5-day SMA:** 331.89
*   **20-day SMA:** 330.90
*   **60-day SMA:** 337.34

**Analysis:**

*   The stock price closed higher than the previous close, indicating positive momentum.
*   The 5-day and 20-day SMAs are below the 60-day SMA, suggesting a potential short-term upward trend but longer term uncertainty.
*   The last price movement {'price': 336.4, 'previousClose': 330.11, 'change': 1.91} suggests a reasonable recent price rebound.

**3) RSI, PPO Index, and Expected Return Analysis:**

*   **MRI (Market Risk Indicator):** 0.8 (Medium Investment)
*   **RSI:** 49.62 (Neutral)
*   **PPO:** 0.1859
*   **Hybrid Signal:** cash_0%_Buy 90% of cash (2 shares - Safe - MRI:0.80) Monthly invest 0.8% of total investment ($1,000.00) (Cash Ratio: 0% on 2026-01-02)
*   **Recent (20 days) relative divergence change:** 3.3 (+): Short-term increase (단기상승)
*   **Expected Return (%):** -236.1% (Significantly Negative)

**Analysis:**

*   The MRI indicates a medium level of investment risk.
*   The RSI is neutral, suggesting the stock is neither overbought nor oversold.
*   The recent divergence change indicates a short-term positive movement.
*   **The expected return is extremely negative, signaling high risk for long-term investment.** The signal indicates a significant underperformance compared to the S&P 500 if held long-term.

**4) Recent News & Significant Events (Yahoo Finance):**

*   **2026-01-02:** UnitedHealth Group (UNH) Prepares for Operational Changes Following External Audit
*   **2025-12-30:** 3 Risks That Can Make UnitedHealth Stock Unattractive
*   **2025-12-31:** UnitedHealth: Valuation Is Reset, Bull Case Is Still Standing Tall (NYSE:UNH)
*   **2026-01-02:** UnitedHealth stock rises today as 2026 opens; UNH holds gains after hours with earnings ahead
*   **2026-01-04:** Penobscot Investment Management Company Inc. Buys 3,774 Shares of UnitedHealth Group Incorporated $UNH
*   **2026-01-03:** UnitedHealth Group Stock (UNH) Opinions on Recent Price Surge and 2026 Outlook

**Analysis:**

*   The news is mixed. An external audit and identification of risks are concerning.
*   The "Valuation is Reset" article and the rise in stock price to start 2026 offer some positive counterpoints.
*   The purchase of shares by Penobscot is also a positive sign, indicating confidence from at least one institutional investor.

**4-2) Analyst Opinions:**

*   **Mean Consensus:** - (~-) (No specific rating provided)
*   **Number of Opinions:** 25
*   **Target Price (avg/high/low):** 392.24 / 440.00 / 280.00

**Analysis:**

*   A large number of analysts are covering the stock.
*   The average target price is significantly higher than the current price, suggesting potential upside, but the low target price is much lower. This shows a wide difference in analyst opinions.

**5) Recent Earnings Analysis:**

| 날짜         | EPS  | 매출        |
|--------------|------|-------------|
| 2025-10-28   | 2.59 | 113.16 B$   |
| 2025-08-11   | 3.76 | 111.62 B$   |
| 2025-05-07   | 6.9  | 109.58 B$   |
| 2024-11-04   | 6.56 | 100.82 B$   |
| 2025-10-28   | 6.56 | 100.82 B$   |

**Analysis:**

*   Revenue is generally trending upwards.
*   EPS shows mixed results and recently has decreased, potentially concerning.

**6) Financial Information:**

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-09-30   | $113.16B  | 18.24%        |
| 2025-06-30   | $111.62B  | 17.93%        |
| 2025-03-31   | $109.58B  | 21.70%        |
| 2024-12-31   | $100.81B  | 21.14%        |
| 2024-09-30   | $100.82B  | 22.84%        |

**Capital and Profitability:**

| Quarter      | Equity    | ROE   |
|--------------|-----------|-------|
| 2025-09-30   | $95.79B  | 2.45% |
| 2025-06-30   | $94.72B  | 3.60% |
| 2025-03-31   | $95.04B  | 6.62% |
| 2024-12-31   | $92.66B  | 5.98% |
| 2024-09-30   | $94.53B  | 6.41% |

**Analysis:**

*   **Revenue:** Consistently increasing.
*   **Profit Margin:** Decreasing recently.
*   **Equity:** Gradually increasing.
*   **ROE (Return on Equity):** Decreasing significantly.

**7) Comprehensive Analysis (Summary):**

*   **Underperformance:** UNH has significantly underperformed the S&P 500 recently.
*   **Volatility:** The MDD figures in the Alpha/Beta table highlight increased volatility.
*   **Negative Outlook:** The extremely negative expected return suggests high risk and potential continued underperformance in the long term.
*   **Mixed News:** News is mixed, with potential operational changes after an audit and highlighted risks offset by positive articles on valuation and a recent price increase.
*   **Decreasing Profitability:** While revenue is increasing, profit margins and ROE have been declining.
*   **Analyst Sentiment:** Analyst price targets suggest potential upside, but there is a wide divergence of opinion.
*   **Technical Indicators:** The RSI is neutral, but the SMA analysis suggests a potential short-term upward trend.
*   **MRI:** Medium risk, but the other factors point to a cautious approach.

**Overall Conclusion:**

Based on the data, UNH appears to be a high-risk investment currently. While there are some positive indicators (rising revenue, recent price increase, some analyst optimism), the significant underperformance compared to the S&P 500, negative expected return, declining profitability metrics, and concerns raised in recent news suggest caution is warranted. The operational changes following the external audit should be monitored closely. While a short-term rebound is possible, the long-term outlook is uncertain.


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.